Paul Manning, the founding CEO of privately owned medicinal cannabis company Helius Therapeutics, has stepped aside from the top job and will consult to the company for the next two years.
The change of leadership in the company had not been signaled until today, when media were tipped off to
Want to read more? It's easy.
Choose your best value subscription option
Student
Exclusive offer for uni students studying at a New Zealand university (valued at $499).
